Skip to main content Accessibility help
×
Home

Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand?

  • Jean-Eric Tarride (a1), Catherine Elizabeth McCarron (a1), Morgan Lim (a1), James M. Bowen (a1), Gord Blackhouse (a1), Robert Hopkins (a1), Daria O'Reilly (a1), Feng Xie (a1) and Ron Goeree (a1)...

Abstract

Objectives: To examine the production of Health Technology Assessments (HTAs) with economic evaluations (EEs) conducted by Canadian HTA agencies.

Methods: This research used a three-step approach: (i) the Web sites of five Canadian organizations promoting HTA were searched to identify HTA reports with EEs; (ii) HTA agencies were surveyed to verify that our information was complete with respect to HTA activities and to describe the factors that influence the HTA process in Canada (i.e., selection of HTA topics, execution, dissemination of results and future trends); (iii) HTAs with EEs were appraised in terms of study design, retrieval of clinical and economic evidence, resource utilization and costing, effectiveness measures, treatment of uncertainty as well as presence of a budget impact analysis (BIA), and policy recommendations.

Results: Two hundred forty-nine HTA reports were identified of which 19 percent included EEs (n = 48). Decision analytic techniques were used in approximately 75 percent of the forty-eight EEs and probabilistic sensitivity analyses were commonly used by all agencies to deal with parameter uncertainty. BIAs or policy recommendations were given in 50 percent of the evaluations. Differences between agencies were observed in terms of selection of topics, focus of assessment and production of HTA (e.g., in-house activities). Major barriers to the conduct of HTAs with EEs were capacity, a lack of interest by decision makers and a lack of robust clinical information.

Conclusions: The results of this research point to the need for increased HTA training, collaboration, evidence synthesis, and use of pragmatic “real world” evaluations.

Copyright

References

Hide All
1. Borowski, HZ, Brehaut, J, Hailey, D. Linking evidence from health technology assessments to policy and decision making: The Alberta model. Int J Technol Assess Health Care. 2007;23:155161.
2. Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada. 3rd ed. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006. http://www.cadth.ca/media/pdf/186_EconomicGuidelines_e.pdf.
3. Drummond, MF, Jefferson, TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313:275283.
4. Drummond, M, Sculpher, M, Torrance, G, O'Brien, B, Stoddart, G. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
5. Goeree, R, Levin, L. Building bridges between academic research and policy formulation: The PRUFE framework – an integral part of Ontario's evidence-based HTPA process. Pharmacoeconomics. 2006;24:11431156.
6. Health Canada. Health Technology Assessment Task Group. Health technology strategy 1.0 final report. June 2004. http://www.cadth.ca/media/corporate/planning_documents/health_tech_strategy_1.0_nov2004_e.pdf.
7. Hivon, M, Lehoux, P, Denis, JL, Tailliez, S. Use of health technology assessment in decision-making: Coresponsibility of users and producers? Int J Technol Assess Health Care. 2005;21:268275.
8. Lehoux, P, Tailliez, S, Denis, JL, Hivon, M. Redefining health technology assessment in Canada: Diversification of products and contextualization of findings. Int J Technol Assess Health Care. 2004;20:325336.
9. Levin, L, Goeree, R, Sikich, N et al. Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: The Ontario experience. Int J Technol Assess Health Care. 2007;23:299309.
10. Menon, D, Topfer, LA. Health technology assessment in Canada. A decade in review. Int J Technol Assess Health Care. 2000;16:896902.
11. van Velden, ME, Severens, JL, Novak, A. Economic evaluations of healthcare programmes and decision-making: The influence of economic evaluations on different healthcare decision-making levels. Pharmacoeconomics. 2005;23:10751082.

Keywords

Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand?

  • Jean-Eric Tarride (a1), Catherine Elizabeth McCarron (a1), Morgan Lim (a1), James M. Bowen (a1), Gord Blackhouse (a1), Robert Hopkins (a1), Daria O'Reilly (a1), Feng Xie (a1) and Ron Goeree (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed